Economic validation and comparison of microbial tryptophan, erythritol and collagen production in an integrated sugarcane biorefinery

IF 3.7 3区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Monique Klaver, Abdul M. Petersen, Jeanne Louw, Johann F. Görgens
{"title":"Economic validation and comparison of microbial tryptophan, erythritol and collagen production in an integrated sugarcane biorefinery","authors":"Monique Klaver,&nbsp;Abdul M. Petersen,&nbsp;Jeanne Louw,&nbsp;Johann F. Görgens","doi":"10.1016/j.bej.2024.109505","DOIUrl":null,"url":null,"abstract":"<div><p>Low sugar prices present a significant challenge to the global sugarcane industry, prompting the exploration of diversification strategies for expanding product portfolios. Techno-economic analyses and environmental sustainability assessments were carried out to evaluate the microbial production of tryptophan, erythritol, and collagen from A-molasses in a biorefinery annexed to an existing sugarcane mill. Tryptophan production exhibited the highest profitability, with a minimum selling price (MSP) at 59.7 % of its current market price, although the achievable production volumes of tryptophan from one sugar mill would oversupply the global market. Due to the larger market size of for collagen the achievable production capacity in the collagen scenario would avoid market saturation, reducing the risk of oversupply and rendering it more economically viable. In contrast, erythritol production was marginally not profitable, with an MSP exceeding the current market price by 1 %, primarily attributed to high operational costs. All scenarios demonstrated relatively low greenhouse gas (GHG) emissions (ranging from 9.1 to 16.5 kg CO2eq/kg product), with tryptophan production emerging as the most environmentally favourable option due to minimal chemical and freshwater usage. When compared with literature-reported data on ethanol and short-chain fructooligosaccharides (scFOS), only collagen and ethanol production were deemed viable, based on their favourable profitability and contribution to the market.</p></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"212 ","pages":"Article 109505"},"PeriodicalIF":3.7000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1369703X24002924/pdfft?md5=ebbb808db23b0919218e353be42c77f8&pid=1-s2.0-S1369703X24002924-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X24002924","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Low sugar prices present a significant challenge to the global sugarcane industry, prompting the exploration of diversification strategies for expanding product portfolios. Techno-economic analyses and environmental sustainability assessments were carried out to evaluate the microbial production of tryptophan, erythritol, and collagen from A-molasses in a biorefinery annexed to an existing sugarcane mill. Tryptophan production exhibited the highest profitability, with a minimum selling price (MSP) at 59.7 % of its current market price, although the achievable production volumes of tryptophan from one sugar mill would oversupply the global market. Due to the larger market size of for collagen the achievable production capacity in the collagen scenario would avoid market saturation, reducing the risk of oversupply and rendering it more economically viable. In contrast, erythritol production was marginally not profitable, with an MSP exceeding the current market price by 1 %, primarily attributed to high operational costs. All scenarios demonstrated relatively low greenhouse gas (GHG) emissions (ranging from 9.1 to 16.5 kg CO2eq/kg product), with tryptophan production emerging as the most environmentally favourable option due to minimal chemical and freshwater usage. When compared with literature-reported data on ethanol and short-chain fructooligosaccharides (scFOS), only collagen and ethanol production were deemed viable, based on their favourable profitability and contribution to the market.

综合甘蔗生物精炼厂中微生物色氨酸、赤藓糖醇和胶原蛋白生产的经济验证与比较
低糖价格给全球甘蔗产业带来了巨大挑战,促使人们探索扩大产品组合的多样化战略。我们进行了技术经济分析和环境可持续性评估,以评估在现有甘蔗厂的附属生物精炼厂中用微生物从 A-淀粉中生产色氨酸、赤藓糖醇和胶原蛋白的情况。色氨酸生产的利润率最高,最低销售价格(MSP)为其当前市场价格的 59.7%,但一家糖厂可实现的色氨酸产量将使全球市场供过于求。由于胶原蛋白的市场规模较大,胶原蛋白方案中的可实现生产能力将避免市场饱和,降低供过于求的风险,使其更具经济可行性。相比之下,赤藓糖醇生产利润微薄,最大生产成本比当前市场价格高出 1%,主要原因是运营成本高。所有方案的温室气体(GHG)排放量都相对较低(从 9.1 到 16.5 千克 CO2eq/千克产品不等),色氨酸生产因化学品和淡水用量最少而成为最环保的方案。与乙醇和短链果寡糖(scFOS)的文献报告数据相比,只有胶原蛋白和乙醇生产因其有利可图和对市场的贡献而被认为是可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biochemical Engineering Journal
Biochemical Engineering Journal 工程技术-工程:化工
CiteScore
7.10
自引率
5.10%
发文量
380
审稿时长
34 days
期刊介绍: The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology. The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields: Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells Bioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信